Association of headache, anxiety, and depression with the treatment of levetiracetam for epilepsy
| Autor: | Nadeem Ikram, Mohammad Jaffar Sadiq Mantargi, Usman Thattarauthodiyil, Saifudheen Kondanath, Muhammad Awais, Easwaran Vigneshwaran |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Microbiology (medical)
medicine.medical_specialty Side effect levetiracetam Immunology Newly diagnosed epilepsy Epilepsy Female patient medicine Immunology and Allergy Drug reaction Psychiatry who umc scale Depression (differential diagnoses) adverse drug reactions naranjo's scale business.industry medicine.disease Anxiety epilepsy Medicine Levetiracetam medicine.symptom business medicine.drug |
| Zdroj: | Saudi Journal for Health Sciences, Vol 10, Iss 2, Pp 143-145 (2021) |
| ISSN: | 2278-0521 |
| Popis: | The current case report bears the details of the adverse drug reactions (ADRs) associated after the administration of the levetiracetam for the management of newly diagnosed epilepsy in a female patient aged 37 years. Datum related to the patient, medications and observed ADRs were noted after getting the consent from the patient during which she has explained her experiences after the beginning of the consumption of the said drug. The Naranjo's scale and World Health Organisation, Uppsala Monitoring Centre scales analysis for the assessment of the correctness of the ADR paved for the certainty of the side effect. Drug regimen modification was initiated by the neurologist after the complaints of uneasiness from the patient after which she was identified to be complying with the other medication. Therefore, it can be said that if any patient on antiepileptic medications experiences discomfort, must bring those issues in light as there is always other options available for the management of the epilepsy without delay. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |